A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
GeoVax Labs, Inc. operates in the Pharmaceutical Preparations industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 3.4M | - | 0 | - | - | 1.8M |
| Net Income | -25M | -25M | -26M | -14M | -19M | -3.0M |
| EPS | $-31.75 | $-120.50 | $-5,358.75 | $-4,646.25 | $-1,140.00 | $-802.50 |
| Free Cash Flow | -24M | -25M | -25M | -19M | -11M | -2.9M |
| ROIC | -299.8% | -393.5% | -366.6% | -52.7% | -125.5% | -21.4% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.62 | 0.61 | 0.18 | 0.00 | 0.04 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -26M | -25M | -27M | -14M | -19M | -2.8M |
| Operating Margin | -761.6% | - | - | - | - | -154.5% |
| ROE | -515.8% | -462.3% | -450.6% | -52.7% | -425.8% | -30.9% |
| Shares Outstanding | 1M | 1M | 0M | 0M | 0M | 0M |
GeoVax Labs, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
GeoVax Labs, Inc. (GOVX) has a 5-year average return on invested capital (ROIC) of -66.6%. This is below average and may indicate limited pricing power.
GeoVax Labs, Inc. (GOVX) has a market capitalization of $2M. It is classified as a small-cap stock.
GeoVax Labs, Inc. (GOVX) does not currently pay a regular dividend.
GeoVax Labs, Inc. (GOVX) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
GeoVax Labs, Inc. (GOVX) generated $-25 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
GeoVax Labs, Inc. (GOVX) has a debt-to-equity ratio of 0.62. This indicates moderate leverage.
GeoVax Labs, Inc. (GOVX) reported earnings per share (EPS) of $-120.50 in its most recent fiscal year.
GeoVax Labs, Inc. (GOVX) has a return on equity (ROE) of -462.3%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 16 years of financial data for GeoVax Labs, Inc. (GOVX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
GeoVax Labs, Inc. (GOVX) has a book value per share of $9.12, based on its most recent annual SEC filing.